Authors


Bryan Fitzgerald, PharmD, BCOP

Latest:

Trilaciclib Protects Against Chemotherapy-Induced Myelosuppression

Treatment's approval marks exciting new development for patients with ES-SCLC to prevent CIM.


Arash Dabestani, PharmD, MHA, FASHP, FABC

Latest:

Technology in the Classroom Helps Shape Tomorrow’s Pharmacy Leaders

Automation can enhance safety and efficiency and allow staff to concentrate on higher-value tasks as direct patient care roles expand.


Rachel E. Barenie, PharmD, JD, MPH

Latest:

The Dilemma of Childhood Vaccines Post Pandemic

With the end of the PREP Act Provisions in sight, pharmacists should Reflect on their impact and plan to continue them.


Raymond DeMatteo, PharmD, BCOP

Latest:

Updates in the Treatment of Moderate to Severe Atopic Dermatitis: A Focus on JAK Inhibitors

Treatment often involves a combination of preventive measures, topical therapies, and systemic treatments.


Xiaoshan Chai, PharmD Candidate

Latest:

Adapting to the FDA's Phenylephrine Status Change in OTC Cold and Congestion Medications

Pharmacists' expertise is crucial in educating patients about regulatory changes, helping them navigate alternative formulations, and providing insights into evidence-based choices.


Syed Ahsan

Latest:

Catalyzing Commitment: The Symphony of AI-Powered Medication Adherence

Artificial intelligence–driven reminders empower patients, combating forgetfulness and enhancing treatment adherence for better health outcomes.


Justin (JC) Liauw, PharmD, BCOP

Latest:

Overview of PARP Inhibitors in the Treatment of Ovarian Cancer

There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.


Cameron Hammers, PharmD Candidate

Latest:

Case Report: Rivastigmine Overexposure Toxicities with Weight Loss

With gastrointestinal-based adverse effectss for rivastigmine and other cholinesterase inhibitors, a weight of <50 and <55 kg respectively leads to an increased risk for toxicities.


Christine Dimaculangan, PharmD, BCACP

Latest:

The Role of the Ambulatory Care Pharmacist in Promoting Vaccine Confidence

A pharmacist’s role in the ambulatory care setting has traditionally included a review of medications for potential drug-drug interactions and adverse events, medication reconciliation, and the provision of counseling services.


Scott Person, PharmD

Latest:

Overcharging Hospital Pharmacies: Unnecessary Hidden Costs

In hospital pharmacies, roughly 2% of pharmacy spend can be overcharge.


Catherine A. Koivisto, RPh

Latest:

The Expanding Role of Continuous Glucose Monitors in Pregnant Patients

The use of CGMs in pregnancy provides clinicians with essential data in real-time, rather than a snapshot given by traditional finger stick testing.


Nazeefa Tabassum, BPS, PharmD Candidate

Latest:

Zuranolone Offers An Innovative Treatment for Postpartum Depression

Zuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.



Micaela Den Hartog, PharmD Candidate

Latest:

Let’s Not Sugar Coat It: HbA1c is the Imperfect Diabetes Diagnostic

When diabetes is uncontrolled, higher percentages of hemoglobin become glycated, which causes elevated HbA1c and glucose levels to rise within the body.


Alyson Houle

Latest:

Updated C. Difficile Infection Guidelines Incorporate New Trials

Infectious Disease Society of America and Society for Healthcare Epidemiology of America make 3 new treatment recommendations for adults.


Arsheeta Kumar, PharmD

Latest:

Pirtobrutinib and BTK Inhibitors in the CLL Treatment Landscape

This review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.


Hannah E. Moore

Latest:

Naloxone Training Requirements Vary Among States

New access laws allow pharmacists to establish standing orders with specific physicians or follow blanket, statewide protocols.


Rena Reid, PharmD

Latest:

Student Exchange Program Crafts Cultural Competency for Pharmacists

An advanced pharmacy practice experience program between a historically Black university and predominantly White institution impacted student perspectives on cultural competency.


Gary Parker

Latest:

Pharma Moves Toward Value-Based Contracting

Part 1 of this 4-part series provides a general overview of the trends that are moving payers and pharmaceutical companies in this direction.


Pearl Steinzor

Latest:

Key Strategies Released for Integrating Equity Into Health Technology Assessment

The Center for Innovation & Value Research has released a final report recommending strategies to ensure health equity is integrated into health technology assessment, which can influence drug pricing and selection by payers, as well as patient access to drugs.


Cradesha Perry, PharmD, MBA

Latest:

Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK Inhibitors

This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.


Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.


Ann Harty, AAHIVP, Fairview Health Service

Latest:

Health System-Based Specialty Pharmacy Offers Unique Advantages in HIV Care

Specialty pharmacists’ roles have grown in new and exciting ways in recent years, and those changes have directly impacted health outcomes for all specialty patients, including patients with HIV.


Sarah Visintainer, PharmD, BCGP, BCMTMS

Latest:

The Role of a Clinical Pharmacist in Melanoma Care and Education

Because of the likelihood that patients with melanoma will develop adverse effects on therapy, it is crucial for pharmacists to proactively educate patients and provide them with tools to help mitigate and manage these issues.


Mary Beth Seipel, PharmD, BCACP

Latest:

Overview of Nurtec ODT for Prevention of Episodic Migraine

Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.


Holly Goetz, PharmD, BCACP, AAHIVP

Latest:

The Role of Pharmacists in HIV Care Continues to Expand

Pharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.


Richard N. Logan Jr., PharmD

Latest:

The Perfect Ingredient: Vaccine Education With Pharmacy Community Health Workers

In Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.


Heather J. Rhodes-Pope, PharmD, MBA, BCPS

Latest:

Providing Food Security From Across the Pharmacy Counter

Pharmacists can play a critical role in addressing food insecurity in their communities, with a variety of tools at their disposal.


Laly Havern, PharmD, MS, BCACP

Latest:

Lower Discontinuation Rates on Cycled Oral Antineoplastics Can Lead to Lower Medical Costs, Fewer Hospitalizations

These agents are likely to become the mainstay of cancer treatment in the very near future.


Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Latest:

CDC and FDA Recommendations for SARS-CoV-2 Booster Shots

Experts in the management of SARS-CoV-2 educate on CDC and FDA recommendations for approaching administration of booster vaccines, including those for special patient populations.